Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on fourth-quarter results that topped the consensus ...
Intra-Cellular Therapies makes Caplyta, a once-daily pill for adults with schizophrenia and bipolar-related depression ...
GlobalData on MSN10d
Update: Johnson & Johnson acquires Intra-Cellular TherapiesJohnson & Johnson (J&J) has announced it will acquire Intra-Cellular Therapies, a company specialising in central nervous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback